Scancell Holdings Plc Stock Net Income

SCNLF Stock  USD 0.14  0.00  0.00%   
Fundamental analysis of Scancell Holdings allows traders to better anticipate movements in Scancell Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Scancell Holdings plc Company Net Income Analysis

Scancell Holdings' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Scancell Holdings Net Income

    
  (2.06 M)  
Most of Scancell Holdings' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scancell Holdings plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Scancell Holdings plc reported net income of (2.06 Million). This is 100.61% lower than that of the Healthcare sector and 102.95% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.36% higher than that of the company.

Scancell Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scancell Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Scancell Holdings could also be used in its relative valuation, which is a method of valuing Scancell Holdings by comparing valuation metrics of similar companies.
Scancell Holdings is currently under evaluation in net income category among its peers.

Scancell Fundamentals

About Scancell Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Scancell Holdings plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scancell Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scancell Holdings plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Scancell Pink Sheet

Scancell Holdings financial ratios help investors to determine whether Scancell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scancell with respect to the benefits of owning Scancell Holdings security.